Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Palisade Bio (PALI) Shares Outstanding (2016 - 2025)

Palisade Bio has reported Shares Outstanding over the past 16 years, most recently at $159.4 million for Q4 2025.

  • Quarterly Shares Outstanding rose 5658.92% to $159.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $159.4 million through Dec 2025, up 5658.92% year-over-year, with the annual reading at $159.4 million for FY2025, 5658.92% up from the prior year.
  • Shares Outstanding was $159.4 million for Q4 2025 at Palisade Bio, up from $9.1 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $159.4 million in Q4 2025 and troughed at $196287.0 in Q4 2022.
  • The 5-year median for Shares Outstanding is $851302.0 (2024), against an average of $10.5 million.
  • Year-over-year, Shares Outstanding plummeted 98.29% in 2021 and then skyrocketed 5658.92% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $284780.0 in 2021, then plummeted by 31.07% to $196287.0 in 2022, then increased by 1.89% to $200000.0 in 2023, then skyrocketed by 1284.32% to $2.8 million in 2024, then skyrocketed by 5658.92% to $159.4 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Shares Outstanding are $159.4 million (Q4 2025), $9.1 million (Q3 2025), and $200000.0 (Q2 2025).